蔡 曜聲

Medicine & Life Sciences

1. Peroxisome Proliferator-Activated Receptors 100%
2. Insulin Resistance 31%
3. Obesity 26%
4. Inflammasomes 26%
5. Adipose Tissue 24%
6. Inflammation 18%
7. 2,4-thiazolidinedione 17%
8. Insulin 17%
9. Leptin 16%
10. Clostridium difficile 15%
11. Genes 15%
12. Kidney 14%
13. Fats 13%
14. Mutation 12%
15. Mitochondrial Dynamics 12%
16. Glucose 11%
17. Adiponectin 11%
18. PPAR gamma 9%
19. Calcium Oxalate Nephrolithiasis 9%
20. Rosiglitazone 9%
21. Ovalbumin 9%
22. Mouse Cybb protein 9%
23. Dialysis 9%
24. Transducers 9%
25. Protein Binding 8%
26. Growth 8%
27. Homeostasis 8%
28. Allergens 8%
29. Adipokines 8%
30. Adipocytes 8%
31. Early Growth Response Protein 1 8%
32. Hepacivirus 8%
33. Nephrolithiasis 8%
34. Phosphotransferases 8%
35. Interleukin-1 7%
36. Embryonic Stem Cells 7%
37. S-layer proteins 7%
38. Adenosine Triphosphate 7%
39. CCAAT-Enhancer-Binding Protein-delta 7%
40. Metabolically Benign Obesity 7%
41. Skeletal Muscle 7%
42. Peritoneal Dialysis 7%